GLENMARK PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Quarterly Results    (GLPH)

Here are the latest quarterly results of GLENMARK PHARMA. For more details, see the GLENMARK PHARMA financial fact sheet and GLENMARK PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GLENMARK PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m27,35627,67523,44829,52527,86828,59929,64931,474 
Other income Rs m330441585-31915185586-131 
Turnover Rs m27,68528,11624,03329,20628,01928,68430,23531,344 
Expenses Rs m22,95523,01818,66723,99722,56723,36523,91325,573 
Gross profit Rs m4,4014,9865,0615,5605,4355,2345,7365,902 
Depreciation Rs m1,0601,2631,1321,0411,1521,1111,1311,232 
Interest Rs m961985937806954833756689 
Profit before tax Rs m2,7103,1803,5763,3943,4803,3754,4363,850 
Tax Rs m8019771,0361,0549981,0361,3701,102 
Profit after tax Rs m1,9082,2032,5402,3402,4822,3393,0652,748 
Gross profit margin %16.118.021.618.819.518.319.318.8 
Effective tax rate %29.630.729.031.128.730.730.928.6 
Net profit margin %7.08.010.87.98.98.210.38.7 
Diluted EPS Rs 6.8 7.8 9.0 8.3 8.8 8.3 10.9 9.7  
Diluted EPS (TTM) Rs 25.4 27.5 32.6 31.9 33.9 34.4 36.2 37.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: GLENMARK PHARMA 1QFY22 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SUN PHARMA    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    

Compare GLENMARK PHARMA With:   SUN PHARMA    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Views on news

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jan 21, 2022 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 5-YR ANALYSIS

COMPARE GLENMARK PHARMA WITH

MARKET STATS